Works begins on new clinical research centre in Belfast
Work has begun on a new multi-million-pound clinical research centre in Belfast.
The £64 million iREACH Health project, which is to create up to 1,000 direct and indirect jobs, is part of the Belfast Region City Deal initiative.
The project, which is being led by Queen's University in partnership with the Belfast Health and Social Care Trust and the Public Health Agency, is also estimated to generate an additional £733 million GDP for the region.
We have started construction on iREACH Health, a new world-class #ClinicalResearch centre on the Lisburn Road.
It is set to open in 2027 and will create up to 1,000 jobs and generate an additional £733 million GDP for #NorthernIreland.
The new centre, which is one of three… pic.twitter.com/tsRZlXrhbw
— Queen's University Belfast 🎓 (@QUBelfast) February 19, 2025
Set to open in Spring 2027, the project is supported by funding from both the UK Government and the Northern Ireland Executive as well as Queen's.
Construction work has got underway at a site on the Lisburn Road beside Belfast City Hospital.
Professor Sir Ian Greer, president and vice-chancellor of Queen's University, said iREACH Health 'signifies a new era for clinical trials in Northern Ireland'.
He said it will bring together world-class expertise and cutting-edge facilities to accelerate the development and deployment of new medical treatments,' he said.
Secretary of State for Northern Ireland, Hilary Benn, hailed iREACH Health as a 'great example of what can be achieved through collaboration with our partners, and of the benefits of the Belfast Region City Deal to support economic growth'.
'This landmark initiative will create new jobs and opportunities in Northern Ireland and I look forward to seeing it helping to shape the future of healthcare across the region,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
01-06-2025
- Hamilton Spectator
Exercise improves colon cancer survival, Canadian researchers say
TORONTO - Canadian researchers say a new study shows regular exercise improves survival for colon cancer patients. The study, published Sunday in the New England Journal of Medicine, found that patients who participated in a supervised exercise program after completing their chemotherapy were 28 per cent less likely to have their colon cancer return than patients in the control group. 'It's the first clinical trial in the world asking whether exercise can improve cancer survival. And in fact, the results were astounding,' Dr. Christopher Booth, a co-chair of the international study and a medical oncologist at Kingston Health Sciences Centre in Kingston, Ont., said in an interview. The patients in the exercise group regularly met with a physical activity consultant — usually a physiotherapist, kinesiologist or personal trainer — to help them stick to a structured exercise program for three years. The patients in the control group received health education materials that encouraged physical fitness after their chemotherapy, but were not given a physical activity support person. The patients in the structured exercise group had a 37 per cent lower risk of death than those in the control group, the study said. The study, which was conducted in cancer centres across Canada and in other countries including Australia and the U.K., shows a prescription for a structured exercise program should be part of the treatment for colon cancer, said Booth, who is also a professor of oncology at Queen's University. 'If we had a cancer drug with this amount of benefit, it would cost between $100,000 and $200,000 per year (and) it would be celebrated in all the major guidelines across oncology societies worldwide,' he said. 'And there's no question it would be funded by health systems worldwide and included as a standard of care.' Although the research team hasn't yet done a formal cost-benefit analysis, Booth said the cost of providing a physical activity support person for three years would likely be between $3,000 and $5,000 per patient. That would be a worthwhile investment for the health-care system to make, he said. 'When we have something like exercise, which is both incredibly affordable and sustainable for health systems with comparable magnitude of benefit, I think it would be a tragic failure of health policy not to ensure this is provided to all patients.' Booth and his colleagues started the randomized control trial, a model widely considered the gold standard in medical research, more than 15 years ago after seeing promising data in observational studies suggesting exercise would benefit colon cancer patients. The trial included 889 colon cancer patients, followed between 2009 and 2024, who had completed their chemotherapy treatments. The researchers assessed their baseline level of fitness and randomized them to assign half the participants to the structured exercise group and the other half to the control group. Those in the exercise group saw a physical activity consultant every two weeks for their first year in the study and then once a month for two years afterward. During those sessions, they would work on motivation and goal-setting to reach their targeted hours of exercise per week. The second part of the session was a supervised exercise session. Their goal was to increase their exercise level by at least 10 metabolic equivalents, or METS, per week. A MET is a unit of energy expended. Participants could choose what exercises they wanted to do as long as they met their MET target. Many chose brisk walking, which adds up to about four METS an hour. One of those participants was Terri Swain-Collins, who lives in Kingston and is one of Booth's patients. Now 62, Swain-Collins was diagnosed with stage 3 colon cancer in June 2021 after a screening test and follow-up colonoscopy. When Booth asked if she would be interested in participating in the study, she didn't know whether she would be in the structured exercise group or the control group. Swain-Collins was assigned to the exercise group. At the time, she was returning to work as a busy X-ray technologist after her treatment, plus helping to manage her husband's business, and wasn't sure where she'd find the time for exercise. Thanks to the physiotherapist assigned to her, she was motivated to walk for at least 45 minutes, three times a week. 'Being accountable to her is what really helped me continue with it,' Swain-Collins said in an interview. 'If I'd have been just told, you know, 'exercise is good for you and off you go,' I never would have done what I'm doing now,' she said. There's no sign of her cancer returning and Swain-Collins said she's 'definitely' more fit now. 'I hope anyone diagnosed with cancer does get this type of opportunity,' she said. 'I think it might really make a difference.' This report by The Canadian Press was first published June 1, 2025. Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
New York Times
01-06-2025
- New York Times
Exercise Extends Life for People With Cancer, Study Shows
A first-of-its kind study adds powerful new evidence to research showing that exercise improves cancer survival. The study, a randomized controlled trial of nearly 900 patients at 55 cancer centers in six countries, showed that people who participated in a structured exercise program lived longer without their cancer coming back and without the occurrence of new cancers. Participants in the exercise program had a 37 percent lower risk of dying and a 28 percent lower risk of recurrent or new cancer than those in the control group. Earlier research had suggested such a benefit, but the data were from observational studies that did not prove a causal link, experts said. 'We now have definitive evidence that exercise is not just an intervention for quality of life and fitness. This is an intervention that improves survival and should be standard of care,' said Dr. Christopher Booth, the senior author of the paper and a professor of oncology at Queen's University in Canada. The study, which was published Sunday in the New England Journal of Medicine, looked at patients with Stage III or high-risk Stage II colon cancer who received standard surgery and chemotherapy treatment. Researchers randomly assigned these patients to a control group, which received educational materials promoting physical activity and healthy nutrition, or to a treatment group, which also received support from a 'physical activity consultant' — a hybrid of personal trainer and life coach — over three years to increase their aerobic exercise and sustain it. Patients could choose a number of activities, such as biking, jogging, swimming or kayaking, but most opted for a brisk walk of 45 minutes four times a week, Dr. Booth said. Eighty percent of patients in the exercise group remained disease-free after five years, compared to 74 percent of patients in the control group. After eight years, the exercise program had prevented one death for every 14 people who participated in the exercise arm of the study. Want all of The Times? Subscribe.
Yahoo
14-04-2025
- Yahoo
Fake weight loss injections arriving to NI 'wrapped in kitchen roll'
Advertised weight loss injections ordered online to Northern Ireland, arrived "wrapped in kitchen roll with no labels or guidance of what they contained", it's been reported. An investigation by BBC News NI revealed that so-called weight loss jabs, bought via social media, were delivered in unhygienic and unsafe conditions. In a report online, it stated that BBC News NI made test purchases from a Facebook account. The seller was based in England and it was claimed that the syringes contained semaglutide, a prescription-only drug. But on arrival to Northern Ireland, they were screened by a Queen's University Professor, and found that they did not contain semaglutide. READ MORE: 'Unlawful distribution and misuse' of Ozempic and Mounjaro prompts Department of Health statement READ MORE: Minister issues update amid 'slushie' drinks glycerol intoxication warning It's reported that the liquid within the syringes was a supplement that can be bought on the high street, by the name of carnitine. The Department of Health said it is continuing to take "decisive action" against the illegal promotion, supply or misuse of medicines in Northern Ireland. It comes after reports of the misuse of medications which are used to treat type 2 diabetes and/or weight loss and weight management in addition to diet and physical activity. A spokesperson for the DoH said their team "remains vigilant" in monitoring "the illicit marketplace". For all the latest news, visit the Belfast Live homepage here and sign up to our daily newsletter here.
